May Hill Capital »

Takeda Pharmaceutical shares owned by May Hill Capital

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by May Hill Capital from 13F filings

Historical chart of May Hill Capital investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by May Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by May Hill Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $253k 14k 18.52

More positions owned by May Hill Capital

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Etf (IWB)
Keysight Technologies (KEYS)
Ishares Core Msci Emkt (IEMG)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Msci Eafe (IEFA)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr National Mun Etf (MUB)
Ishares Tr Core S&p Scp Etf (IJR)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Blackrock Etf Trust Ii Ishares Total Re (BRTR)
Vanguard Index Fds Small Cp Etf (VB)

View all positions for May Hill Capital

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Brandes Investment Partners
FMR
BlackRock
UBS Group
Renaissance Technologies
D. E. Shaw & Co
Van Eck Associates Corp.
Citadel Advisors
First Trust Advisors
Managed Asset Portfolios
Northern Trust

View all funds holding Takeda Pharmaceutical